GlaxoSmithKline S.A.E announced consolidated and standalone earnings results for the first quarter ended March 31, 2018. For the quarter, on consolidated basis, the company’s net profit was EGP 22,066,348 compared with net comparative profit of EGP 18,216,449 a year ago. For the quarter, on standalone basis, the company’s net profit was EGP 20,703,763 compared with net comparative profit of EGP 16,709,229 a year ago.